Expert Insights On Downstream Bioprocessing
-
End-To-End mRNA DS And DP Manufacturing Processes
7/10/2024
This article demystifies the manufacture of mRNA encapsulated in lipid nanoparticles across unit operations for plasmid linearization, drug substance (DS) manufacture, and drug product (DP) manufacture.
-
Does Single-use Seem Daunting? Try Starting With Standard Assemblies
7/8/2024
You might not need to outfit your whole facility to take advantage of single-use technology. Assemblies offer a straightforward path to standardizing equipment.
-
Using The ADKAR Model In Biopharma Change Management
7/8/2024
Biopharma companies dedicated to continuous improvement are the ones that dominate their market sector. Using the ADKAR model of change management can help.
-
Making Cancer Vaccines Is Complex; New Platform Guidance Could Help
7/3/2024
FDA's draft guidance on platforms is mostly for established, well-characterized modalities, but it also has implications for the emerging area of personalized medicine.
-
Strategies To Tackle CAR-T Product Challenges
6/24/2024
This article describes strategies for scaling up production of CAR-T products, including the hub model, bedside model, innovation of process strategy, and more.
-
How Mechanistic Modeling Eases Wet Lab Dependence
6/20/2024
Mechanistic modeling mimics process steps in a computational environment, thereby substantially reducing the dependence on physical experiments.
-
Does Flow Play A Role in Protein Aggregation During Bioprocessing?
6/7/2024
We know about many factors that trigger protein aggregation, but does fluid flow itself play a part? These scientists at the University of Leeds are working to find out.
-
Points To Consider For Assessing Lipid Quality For Lipid Nanoparticle Manufacturing
5/29/2024
Lipid nanoparticles have generated a ton of buzz, but they pose risks that, perhaps, industry and regulators have not taken seriously enough so far.
-
7 Steps To Accelerate Biopharma Manufacturing Processes
5/21/2024
Now more than ever, manufacturing capability can make or break success. To navigate the challenges, small biopharma companies must adopt these strategic approaches.
-
How Advanced PAT Aids Quality By Digital Design In mRNA Manufacturing
5/15/2024
QbDD is an improvement over the QbD paradigm. Here, computational models are used to characterize, monitor, control, and improve manufacturing processes.